Table 2.
Weight outcomes at 14 days and 6 months
| 14 Days | 6 Months | |||||||
|---|---|---|---|---|---|---|---|---|
| Azithromycin Mean (SD) |
Placebo Mean (SD) |
Mean Difference or Odds Ratioa (95% CI) | P-value | Azithromycin Mean (SD) |
Placebo Mean (SD) |
Mean Difference or Odds Ratioa (95% CI) |
P-value | |
| Growth velocity, g/kg/day | 2.1 (3.2) | 1.2 (4.0) | 0.9 (0.3 to 1.5) | 0.01 | 0.6 (0.4) | 0.5 (0.6) | 0.04 (−0.05 to 0.1) | 0.46 |
| Weight, kg | 11.5 (3.0) | 11.8 (2.9) | 0.12 (0.01 to 0.24) | 0.035 | 12.5 (3.0) | 12.6 (2.8) | 0.07 (− 0.07 to 0.22) | 0.32 |
| Mid-upper arm circumference, cm | 14.3 (1.2) | 14.5 (1.1) | −0.008 (− 0.1 to 0.1) | 0.91 | 14.3 (1.2) | 14.5 (1.0) | −0.1 (− 0.25 to 0.03) | 0.12 |
| Weight-for-height Z-score | −0.5 (1.0) | − 0.30 (1.1) | − 0.001 (− 0.1 to 0.1) | 0.98 | −0.8 (1.1) | − 0.6 (1.0) | −0.04 (− 0.2 to 0.11) | 0.63 |
| Weight-for-age Z-score | −0.8 (1.0) | − 0.7 (1.1) | 0.08 (− 0.01 to 0.02) | 0.07 | −0.9 (1.0) | − 0.8 (1.0) | 0.04 (− 0.07 to 0.14) | 0.51 |
| MUAC< 12.5 cm | 7.8% | 3.4% | 1.9 (0.5 to 6.7) | 0.32 | 3.0% | 0.5% | 4.9 (0.5 to 44.2) | 0.16 |
| Wasted (WHZ < -2) | 6.0% | 5.4% | 0.7 (0.3 to 1.9) | 0.49 | 13.4% | 11.1% | 0.5 (0.2 to 1.3) | 0.16 |
| Underweight (WAZ < -2) | 13.8% | 10.3% | 0.4 (0.3 to 1.9) | 0.08 | 9.5% | 8.4% | 0.9 (0.4 to 2.0) | 0.78 |
aAll models included a term for the randomized treatment assignment, and all models except for the g/kg/day outcome were adjusted for the baseline measurement of the outcome